Cost-effectiveness of camrelizumab plus rivoceranib for advanced hepatocellular carcinoma in the context of regional disparities in China - Zhao, Zhonghua; Jiang, Xiongying; Wen, Shiping; Hao, Yanzhang (Frontiers in Oncology, 2024)